Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (151-160 of 492) with videos related to

Pageof 50
Sort By:
Expert Review of Vaccines|September 13, 2024
A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccinesMary Bausch-Jurken, Rachel S Dawson, Francesca Ceddia, et al.
Antimicrobial Agents and Chemotherapy|January 2, 2016
Erratum for Bueno et al., Coproduction of 16S rRNA Methyltransferase RmtD or RmtG with KPC-2 and CTX-M Group Extended-Spectrum β-Lactamases in Klebsiella pneumoniaeMaria Fernanda C Bueno, Gabriela R Francisco, Jessica A O'Hara, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2017
Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative PathogensRyota Ito, Adam D Tomich, Christi L McElheny, et al.
International Journal of Antimicrobial Agents|December 16, 2017
Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumanniiSarunyou Chusri, Ittichai Sakarunchai, Narongdet Kositpantawong, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2013
Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogensBerthony Deslouches, Jonathan D Steckbeck, Jodi K Craigo, et al.
Jac-Antimicrobial Resistance|June 5, 2026
<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in JapanKatsunori Yanagihara, Kazuhiro Tateda, Yohei Doi, et al.
Infection Control and Hospital Epidemiology|April 23, 2023
Discontinuation of admission screening for coronavirus disease 2019 (COVID-19) and the impact on in-hospital clusters of COVID-19: Experience at a tertiary-care centerHitoshi Honda, Masataka Nakagawa, Rie Nisida, et al.
The Pediatric Infectious Disease Journal|May 15, 2002
Characterization of Klebsiella pneumoniae and Escherichia coli strains that produce CTX-M-2-type broad spectrum beta-lactamase isolated from a child with leukemiaToshiya Ohkawa, Masao Yoshinaga, Naoaki Ikarimoto, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
Lack of seasonality in the occurrence of multidrug-resistant Acinectobacter baumannii complexYuriko Fukuta, Lloyd G Clarke, Ryan K Shields, et al.
Emerging Infectious Diseases|March 2, 2025
Cefotaxime-Resistant Neisseria meningitidis Sequence Type 4821 Causing Fulminant MeningitisYouxing Shao, Mingliang Chen, Jiehao Cai, et al.
Pageof 50

Showing results (151-160 of 492) with videos related to

Sort By:
Pageof 50
Expert Review of Vaccines|September 13, 2024
A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccinesMary Bausch-Jurken, Rachel S Dawson, Francesca Ceddia, et al.
Antimicrobial Agents and Chemotherapy|January 2, 2016
Erratum for Bueno et al., Coproduction of 16S rRNA Methyltransferase RmtD or RmtG with KPC-2 and CTX-M Group Extended-Spectrum β-Lactamases in Klebsiella pneumoniaeMaria Fernanda C Bueno, Gabriela R Francisco, Jessica A O'Hara, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2017
Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative PathogensRyota Ito, Adam D Tomich, Christi L McElheny, et al.
International Journal of Antimicrobial Agents|December 16, 2017
Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumanniiSarunyou Chusri, Ittichai Sakarunchai, Narongdet Kositpantawong, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2013
Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogensBerthony Deslouches, Jonathan D Steckbeck, Jodi K Craigo, et al.
Jac-Antimicrobial Resistance|June 5, 2026
<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in JapanKatsunori Yanagihara, Kazuhiro Tateda, Yohei Doi, et al.
Infection Control and Hospital Epidemiology|April 23, 2023
Discontinuation of admission screening for coronavirus disease 2019 (COVID-19) and the impact on in-hospital clusters of COVID-19: Experience at a tertiary-care centerHitoshi Honda, Masataka Nakagawa, Rie Nisida, et al.
The Pediatric Infectious Disease Journal|May 15, 2002
Characterization of Klebsiella pneumoniae and Escherichia coli strains that produce CTX-M-2-type broad spectrum beta-lactamase isolated from a child with leukemiaToshiya Ohkawa, Masao Yoshinaga, Naoaki Ikarimoto, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
Lack of seasonality in the occurrence of multidrug-resistant Acinectobacter baumannii complexYuriko Fukuta, Lloyd G Clarke, Ryan K Shields, et al.
Emerging Infectious Diseases|March 2, 2025
Cefotaxime-Resistant Neisseria meningitidis Sequence Type 4821 Causing Fulminant MeningitisYouxing Shao, Mingliang Chen, Jiehao Cai, et al.
Pageof 50